The insertion of 32 amino acids coded by exon 38 of ARHGEF11 observed in invasive breast cancer cells abolished its interaction with ZO-1 and changed its subcellular localization from cell-cell junctions to cell edge and cytoplasm. This evidence concerns the gene TJP1 and invasive breast carcinoma.